targeted therapy and immunotherapy are the regular treatments for lung cancer. Considering individuals response differently even with the same histopathologic type
immunohistochemical index
TNM stage or mutation status
it is critical to find a robust biomarker to early predict therapeutic responses. Artificial intelligence could analyze medical images thoroughly and quantitatively and shows huge applicable potential in lung cancer diagnosis and prognosis. In this paper
the application of artificial intelligence in the therapeutic response evaluation and prediction of lung cancer were reviewed and discussed.